michal roll: Clinical Trials

7 trials sponsored by michal roll, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 unknown, 1 recruiting, 1 terminated. 3 Not applicable, 2 Phase 4, 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable3Unknown 3
Phase 42Unknown 2
Phase 21Recruiting 1
Phase 31Terminated 1

Follow michal roll: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ocular Point of Care Ultrasound (POCUS) to Detect Optic Disc Swelling in Comparison to Ophthalmologic Examination
Point of care ocular ultrasound - Papilledema Associated With Increased Intracranial Pressure
Not applicableUnknownmichal roll3002017-01-012016-12-14
Burnout Preventions, Professionalism Heightening, and Enhancing Resiliency (BUPHER)
Preventing Professionals burnout - Professional-Patient Relations, Burnout, Professional
Not applicableUnknownmichal roll10002016-11-012016-11-15
Mediterranean Diet as an add-on Therapy for Induction of Remission in Patients With Active Crohn's Disease
Mediterranean diet, Low residue diet - Crohn's Disease
Not applicableUnknownmichal roll1002016-07-012016-07-07
Erythromycin Treatment for Readthrough of APC Gene Stop Codon Mutation in Familial Adenomatous Polyposis-minors' Adjusted Version
Erythromycin - FAP-Familial Adenomatous Polyposis
Phase 4Unknownmichal roll152015-06-012015-02-03
The Effect of Duloxetine on Mood, Quality of Life and Cognitive Functioning in Glioblastoma Patients
duloxetine, PLACEBO - Depression
Phase 3Terminatedmichal roll502015-05-012015-12-03
Erythromycin Treatment for Readthrough of APC Gene Stop Codon Mutations in Familial Adenomatous Polyposis
Erythromycin - FAP-Familial Adenomatous Polyposis
Phase 4Unknownmichal roll202014-06-012014-06-26
Safety and Efficacy Study Using 5-ALA Oral Administration as an Adjuvant Therapy on the Rate of Local Tumor Recurrence in Patients Who Have Desmoids Tumors
5-AMINOLEVULINIC ACID (5-ALA), is a non fluorescent prodrug. - The Aim of the Study is to Evaluate the Efficacy of Photodynamic Therapy as an, Adjuvant Therapy on the Clinical Outcome of Patients With Desmoid Tumors After
Phase 2Recruitingmichal roll1402013-06-012013-10-31

Conditions studied

Adenomatous Polyposis Coli (2)  ·  Burnout, Professional (1)  ·  Crohn Disease (1)  ·  Depression (1)  ·  Glioblastoma (1)  ·  Inflammatory Bowel Diseases (1)  ·  Papilledema (1)

Interventions

Erythromycin (2)  ·  Aminolevulinic Acid (1)  ·  Diet, Mediterranean (1)  ·  Duloxetine Hydrochloride (1)

Countries

Israel (2)

Top investigators

Iris Dotan, MD (1)  ·  Jacob Bickels, MD/PhD (1)  ·  Rachel Grossman, MD (1)  ·  Revital Kariv, MD (1)  ·  Revital Kariv, MD. (1)  ·  Rina Rosin-Arbeseld, Ph.D (1)  ·  Rina Rosin-Arbeseld, Ph.D. (1)

Results publications

PMID 20018966, PMID 24563781